Introduction
The Rho GTPases form a distinct subgroup of the Ras superfamily of low molecular weight GTP binding proteins. These proteins are implicated in signal transduction leading to changes in membrane structures and cytoskeletal reorganisation associated with changes in cell shape. Like other Ras-related proteins, Rho GTPases are thought to adopt either an active GTP-bound conformational state or an inactive GDPbound state. Although cycling between these states is controlled by several regulatory proteins, mutations in Rho proteins can favour a specific status : an asparagine substitution in Rho at position homologous to Ras threonine 17 led to a drop in the affinity for GTP. This mutated protein acts as an inhibitor by sequestering positive regulatory factors thereby preventing activation of the endogenous Rho GTPase. Conversely, substitutions of residues similar to those found in oncogenic Ras proteins (e.g. G12V or Q61L) led to constitutively active Rho proteins, due to a reduced GTP hydrolysis. Once loaded with GTP, the GTPase gains the ability to bind cognate effector downstream targets, which converts the input signal into a specific set of activations.
Over the past few years, it has been shown that Rho GTPases play a role in the organisation of the actin cytoskeleton, and also have critical functions in the control of cell proliferation. In the present review, I address the implication of the Rho family in cell transformation and apoptosis, as well as in the regulatory crosstalk between pathways controlled by Rho and Ras proteins.
The Rho family
Rho proteins are key elements in the regulation of numerous functions such as the assembly of the cytoskeleton 1 , cell motility 2 , smooth muscle contraction 3 , metastasis 4 , apoptosis 5 , as well as various aspects of cell polarity. The Rho family is made of two branches, one comprising RhoA 6 , RhoB and RhoC 7 , RhoD 8 , RhoE 9 and RhoL 10 , the
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other comprising Rac1 and Rac2 11 , Rac3 12, 13 , RhoG 14 , Cdc42Hs 15 , TC10 16 and TTF 17 .
RhoA, RhoB and RhoC control the formation of focal adhesions and actin stress fibres in fibroblasts [18] [19] [20] , while RhoD causes rearrangements of the actin cytoskeleton and controls early endosome motility and distribution 8 . Rac proteins are required for growth factorinduced membrane ruffling and lamellipodia formation in fibroblasts 1, 18 . Additionally, in neurons, their activity is required for axonal outgrowth 21 while in phagocytic cells, they play a role in the activation of NADPH oxidase [22] [23] [24] [25] . Cdc42 is involved in the establishment of cell polarity in yeast 26, 27 and the mammalian homologue Cdc42Hs is required in the polarization of helper T cells toward antigen-presenting cells 28 . Cdc42Hs
also regulates the formation of filopodia in growth stimulated fibroblastic cells 29 . In addition to their role in cell morphology, Rho, Rac and Cdc42Hs have been shown to promote cell cycle progression through G 1, trigger DNA synthesis 30 and regulate the activation of the ubiquitous transcription factor SRF (serum response factor) 31 . However, the effect induced by Cdc42Hs is still controversial, as other reports indicate that its expression causes cytokinesis arrest 32 , and inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring the MAP kinase p38/RK 33 . Rac, Cdc42Hs and RhoG also stimulate the c-Jun kinase JNK/SAPK, an enzyme essential in the signalling pathways from IL-1 or TNFα receptors 34, 35 .
Regulators of the Rho family and their oncogenic properties
The transition between GTP-bound and GDP-bound conformational states of the Rho GTPases is controlled by a wide array of regulatory proteins : guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs) and GDP-dissociation inhibitory factors (GDIs). So far, only three GDIs proteins have been characterized, namely RhoGDI, D4/LyGDI and γ-GDI/RhoGDI3. RhoGDI is ubiquitously expressed in mammalian tissues and organs 36 , while D4/LyGDI expression is restricted to hematopoietic tissues 37, 38 . γ-GDI/RhoGDI3 is preferentially expressed in the brain and pancreas 39 , and has a binding specificity for RhoB and RhoG 40 .
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A high number of GAPs acting on the Rho family have been isolated. They include p190 41 68 , abr 44 , dbs 69 , lbc 70 , lfc 71 and lsc 72 . Like GAPs, GEFs factors exhibit a wide diversity in their tissue distribution and specificity towards Rho members.
Thus, only proteins capable of activating one or several Rho proteins have oncogenic properties 73 . A direct link between activation of Rho GTPases and cell transformation has been demonstrated by the finding that the GEF activity of the dbl exchange factor is required for cell transformation 62 . Since that GEFs may activate one or several Rho GTPases, this resulted to the hypothesis that one or several pathways controlled by Rho proteins are involved in cell transformation.
Rho proteins and cell transformation

Intrinsic transforming properties of Rho proteins
During the last ten years, several studies have investigated the transforming potential of the Rho family members. It was first observed that although expression of activated RhoA (V14-RhoA) in NIH3T3 cells did not cause focus formation in monolayers or growth in soft agar, it led to a reduced dependence on serum for growth, a higher saturation density and a tumourigenic potential in nude mice 74 Although expression of activated Cdc42Hs protein (V12-Cdc42Hs) in Rat1 or NIH3T3 cells led to a dramatic loss of anchorage dependence, it had no effect on serumdependent growth and on contact inhibition 35, 80 . Interestingly, V12-Cdc42Hs-expressing Rat1 cells readily produced tumours in nude mice 80 but did not form foci 35 . These cells showed a high membrane activity, which were generally multinucleated with a rounded phenotype and a reduced adhesion to the substratum 80 . 
Crosstalk between Rho controlled pathways
In contrast with the low focus forming activity of cells transfected with GTPases, cells expressing exchange factors display a high focus forming activity. As exchange factors can activate several distinct GTPases, this suggests a probable cooperation between Rho-controlled pathways. For instance, the Ost exchange factor potentially acts on RhoA and Cdc42Hs, and also has the ability to bind the GTP-bound form of Rac1 65 .
Thus, the activated Ost protein might express its full oncogenic properties through the activation of three distinct Rho-dependent pathways.
Analysis of coordinated crosstalk has been worked out by coexpressing various combinations of constitutively active and dominant negative Rho protein variants.
Whereas constitutively active individual Rho GTPases showed very weak focus forming activities, their simultaneous expression results in much higher focus formation 35 :
Coexpression of V12-Cdc42Hs and V12-Rac1, or V12-Cdc42Hs and V12-RhoG produced a high focus forming activity, in the range of that observed for Ost 65 . Coexpression of V12-RhoG and V12-Rac1 elicited a focus forming activity an order of magnitude lower 35 .
Interestingly, coexpression of N17-Rac1, a dominant negative Rac, caused an 80% inhibition in the focus forming activity of cells expressing V12-Cdc42Hs and V12-RhoG, while expression of N17-RhoG and N17-Cdc42Hs only marginally reduced the focus formation elicited by V12-Rac1/V12-Cdc42Hs and V12-Rac1/V12-RhoG, respectively.
This suggests that Rac acts downstream of RhoG in a pathway independent from
Cdc42Hs. Along the same line, coexpression of V12-Cdc42Hs and N17-Rac1 strongly inhibited the generation of multinucleated cells as well as PDGF-induced lamellipodia 80 .
In contrast, anchorage-independent growth in soft agar was not significantly inhibited.
This suggests that Cdc42Hs might control at least two distinct pathways: one pathway responsible for lamellipodia and cleavage furrow formation where Cdc42Hs is upstream of
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Rac, and a second Rac-independent pathway, which controls anchorage-independent cell growth.
Thus, although Cdc42Hs was shown to act upstream of Rac1 in pathways signalling cytoskeletal reorganization of various cell types 29, [82] [83] [84] , we can conclude that Rac1 and Cdc42Hs delineate at least two independent pathways that cooperate in cell transformation ( Figure 1 ). Cdc42Hs controls the anchorage-dependent cell growth, while
Rac1 controls cell contact inhibition. RhoG appears to be involved in some of the same pathways as Rac1, probably acting upstream of Rac. However, RhoG is also involved in different pathways, as it cooperates independently with Rac1 and Cdc42Hs in focus formation.
The observation that Rho-dependent pathways leading to cell transformation follow a scheme that does not superimpose with the regulatory cascade described for the control of actin cytoskeleton (see page 7). This suggests that the expression of V12-Cdc42Hs only partially activates the endogenous Rac1 protein, e.g. by acting only on Rac1 localised in specific sub-cellular domains or by increasing at a lower extent the amount of GTP-bound Rac1. 80 . N17-Cdc42 was shown to revert the transformed morphology of Rasexpressing cells whereas N17-Rac1 did not. Conversely, expression of N17-Rac1 strongly inhibited low-serum growth of Ras-transformed cells, whereas N17-Cdc42Hs had a limited effect. Both proteins strongly inhibited cell growth in soft agar.
Crosstalk between Ras and Rho-dependent pathways in cell transformation
Cooperation between Ras and Rho pathways
The overall inhibitory effect of N17 variants was not due to a toxic effect, as their expression at similar levels induced minimal changes in NIH3T3 cells: N17-Rac1 and N17-RhoG expression led to a reduction in cell saturation density but did not modify cell growth in 10% foetal calf serum 35, 77 , while no changes in morphology or cell growth were reported in N17-Cdc42Hs-expressing cells 35, 80 . Expression of N19-RhoA did not reduce cell cloning efficiency, although it led to a reduction in stress fibre formation 81 . In addition to inhibitory mutants, overexpression of p190-RhoGAP [which has marked preferential activity for Rho(A,B,C) in vitro [Ridley, 1993 #108] ] was recently shown to suppress HaRas mediated cell transformation 89 . This demonstrates that the amount of intracellular GTP-bound Rho is critical for Ras transformation. Thus, although the possibility remains that some mutants inhibit non specifically distinct Rho proteins, these data suggest that multiple pathways controlled by Rho proteins are necessary for full Ras-dependent transformation.
The implication of Rho-dependent pathways in cell transformation was further strengthened by the phenotypic changes observed in cells coexpressing activated Ras
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and Rho proteins. L63-RhoA or I115-Rac1 expression led to a twofold increase in the number of L61-Ras-induced foci 88 . Similarly, a 3-fold to 4-fold increase in activated Ras focus forming activity was observed upon coexpression with V12-Rac1, and to a lower extent, with V12-RhoG and V12-Cdc42Hs 35 . In addition, the morphology of the resulting foci was dramatically altered. Whereas cells expressing L61-Ras were highly refractile and spindle-shaped, coexpression with L63-RhoA or I115-Rac1 produced foci with rounded refractile and poorly adherent cells.
Thus, these data are consistent with the hypothesis that distinct Rho-dependent pathways are important in Ras-mediated transformation. Even though Rho GTPases do not induce focus formation on their own, they synergize with Ras, suggesting that Rho proteins modulate the susceptibility of NIH3T3 cells to Ras-mediated transformation (Figure 2 ).
Cooperation between Raf and Rho pathways
Ras-dependent signal transduction has been extensively studied over the past ten In conclusion, the recent literature indicates that Ras transformation is mediated by at least two distinct Raf/ERK-independent pathways, which might be controlled by Rho proteins (Figure 2 ). It now remains to determine which pathways might be involved in cell Additionally, recent reports showed that JNK/SAPK was associated with cell transformation [101] [102] [103] [104] . Characterization of the kinases acting upstream of JNK/SAPK led to the identification of MEKK1 and PAK, homologues of the yeast STE11 and STE20
proteins, respectively [105] [106] [107] [108] [109] . The PAK family (p21-activated kinases) consists in three conserved members that were first isolated by their ability to be autophosphorylated and actived upon binding to GTP-bound Rac1 and Cdc42Hs (reviewed in 110 (Figure 3 ).
Whether JNK and PAK pathways are used by other Rho GTPases to cooperate with Raf remains to be investigated.
The cytoskeleton and Rho proteins
As mentioned earlier, oncogenic transformation is associated with changes in morphological characteristics of the cell, i.e. decreased anchorage dependent cell growth, invasiveness and reduction in cell contact inhibition, which appear controlled by Rho members. Various Rac1 and Cdc42Hs proteins mutated in their effector domains such as C40-Rac1 and C40-Cdc42Hs no longer interact with PAK and cannot activate the JNK pathway, but still induce cytoskeletal changes and G1 cell cycle progression 120 .
Conversely, 37A-Rac1 can bind PAK and activates the JNK pathway, but no longer interacts with POR1, and does not induced lamellipodia formation, G1 cell cycle progression and cell transformation in association with Raf-CAAX 113, 120 . In all instances, the formation of filopodia and lamellipodia induced by Cdc42Hs and Rac1 was associated with their ability to cooperate with Raf in cell transformation. However, whether both events are functionally linked remains to be determined.
Recent published work suggest that the relationships between morphological characteristics and transformation are more complex than initially suspected. Tiam1, a dbl-like protein, was isolated as a result of its role in invasion and metastasis in T- A third indirect set of experiments dealing with PAK activity suggests that morphological changes might be dispensable for cooperation of Rho proteins in transformation. Indeed, as previously mentioned, PAK activation is thought to be required for Ras but not Raf-CAAX transformation 112 . A GST-PAK fusion, constitutively active in vitro 121 , rapidly elicited filopodia and lamellipodia formation 122 , similar to the effects observed upon introduction of V12-Cdc42Hs and V12-Rac1. This was confirmed by transfecting HeLa cells and fibroblasts with plasmids encoding constitutively active PAK, mutated at its autophosphorylation sites 123 . Such expression caused loss of stress fibres and focal adhesions. These effects were also similar to those observed upon expression of V12-Cdc42Hs or V12-Rac1. Therefore both reports indicate that PAK activity might be necessary for Cdc42Hs-and Rac1-dependent actin reorganization. If so, the observation that PAK activity is dispensable for Raf-CAAX focus forming activity suggests that morphological modifications delineate a pathway distinct from the one involved in transformation ( Figure 3 ).
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In conclusion, although overall changes in cellular morphology are undoubtedly crucial for the process of cell transformation, there is still a lack of evidence that Rho proteins use pathways leading to cytoskeletal reorganization to cooperate in cell transformation.
Rho proteins and apoptosis
Programmed cell death (also termed apoptosis) is a conserved active cellular mechanism involved in the control of many normal physiological processes, such as development and differentiation, or in pathological aspects such as tumourigenesis 124, 125 .
Apoptosis is characterized by cell membrane blebbing, phosphatidylserine externalization, 
Concluding remarks
The specific mutations in the effector domain were reported to differentially decrease in vitro or in levuro the affinity for particular target proteins. However, the effective loss of a specific binding within the cell (i.e. the absence of any activation) remains to be settled. iv)
Expression of active and inhibitory mutated proteins sometimes produce identical phenotypic effects. Wild-type, N17-or V12-Cdc42Hs were reported to inhibit G 1 /S progression to the same extent 33 , and expression of N19-RhoA was shown to promote stress fibres formation 81 .
Despite these limitations, it emerges from this survey that Rho proteins control multiple pathways that cooperate in cell transformation. Two pathways are now firmly established : one is controlled by RhoG and Rac, and modulates cell contact inhibition, while the other is governed by Cdc42Hs and RhoA, and affects anchorage-independent cell growth. The precise molecular mechanisms underlying these biological features is still debated. The implication of other pathways is also suspected, although they remained to be characterized. Additionally, only a limited number of Rho family members have been so far studied in detail, which leaves open a wide range of unknown pathways that might also influence physiological parameters critical for cell transformation. Finally, recent data support a crucial function of Rho proteins in the signalling of the apoptotic signal, whose perturbation constitutes an alternative for a cell to escape growth control.
In all instances, activities of Rho proteins appear tightly linked each to one another, according to a complex network of regulatory crosstalk. Deciphering of such network, and of relationships bridging Ras and Rho proteins will prove valuable for a better understanding of tumourigenesis.
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Figure1: Model for cooperativity of Rho GTPases in focus formation. Cdc42Hs and RhoA promote anchorage-independent growth, while RhoG and Rac reduce cell contact inhibition. The simultaneous activation of both pathways leads to a high focus forming activity. RhoG is thought to act mainly upstream of Rac, although additional cooperative effects are suspected. hal-00875311, version 1 -21 Oct 2013
